Clinical Trials for Oligometastatic Prostate Carcinoma

Find clinical trials for oligometastatic prostate carcinoma. Discover research opportunities and treatment options in your area.

8 Active Trials Found

Showing 8 trials on this page

Page 1 of 1

Addressing Health Literacy With a Tailored Survivorship Care Plan

NCT ID: NCT06674863

This clinical trial is looking at how a special care plan can help Black or African American men with prostate cancer better understand and access the care they need after treatment. The study comp...

Not yet recruiting

Phase: NA Type: interventional Locations: Atlanta, Georgia, United States, Atlanta, Georgia, United States +1 more

Risk Stratified De-escalated Hormone Therapy With Radiation Therapy for the Treatment of Prostate Cancer

NCT ID: NCT06369610

This clinical trial is studying a new way to treat high-risk prostate cancer using less hormone therapy combined with radiation. The goal is to see if giving fewer hormone treatments, based on the ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Scottsdale, Arizona, United States

SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma

NCT ID: NCT06205316

This clinical trial is comparing two types of radiation therapy for men with prostate cancer that has either come back after treatment or spread to a few other places in the body. The trial is spec...

Recruiting

Phase: PHASE3 Type: interventional Locations: Scottsdale, Arizona, United States, Rochester, Minnesota, United States +4 more

Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study

NCT ID: NCT05053152

This clinical trial is looking at how well a drug called relugolix works when combined with standard radiation therapy for men with advanced-stage prostate cancer that has spread in a limited way t...

Recruiting

Phase: PHASE2 Type: interventional Locations: Cleveland, Ohio, United States, Milwaukee, Wisconsin, United States +244 more

[Ac-225]-PSMA-62 Trial in Oligometastatic Hormone Sensitive and Metastatic Castration Resistant Prostate Cancer

NCT ID: NCT06229366

The [Ac-225]-PSMA-62 trial is a research study looking at a new treatment for prostate cancer that has spread, specifically targeting prostate-specific membrane antigen (PSMA) positive tumors. The ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Montreal, Quebec, Canada, Toronto, Ontario, Canada +8 more

OLIGOS: Impact of Treatment on Primary Tumour in Patients With Newly Diagnosed Oligometastatic Neoplasia of the Prostate

NCT ID: NCT06273345

The OLIGOS trial is studying how different treatments affect men who have recently been diagnosed with oligometastatic prostate cancer, which means they have a limited number of cancer spots that h...

Recruiting

Type: observational Locations: Padova, , Italy, Padova, , Italy +10 more

Accuracy of 18F-rhPSMA-7.3 PET/ MRI for Prediction of Lymph Node Metastasis in Localized High-Risk Prostate Cancer

NCT ID: NCT06389786

This clinical trial is looking at a special type of imaging scan called 18F-rhPSMA-7.3 PET/MRI. This scan helps doctors see if prostate cancer has spread to the lymph nodes in men who are at high r...

Recruiting

Phase: NA Type: interventional Locations: Jacksonville, Florida, United States, Jacksonville, Florida, United States

Neoadjuvant Radiohormonal Therapy for Oligometastatic Prostate Cancer

NCT ID: NCT05707468

This clinical trial is investigating new treatment options for men with oligometastatic prostate cancer, which means their cancer has spread to a limited number of places, like a few bones or lymph...

Not yet recruiting

Phase: NA Type: interventional Locations: Shanghai, , China, Shanghai, , China +9 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions